{"id":"W2608461130","doi":"10.1200/jco.2017.72.8030","title":"Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion","year":2017,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Hormonal therapy; Abiraterone acetate; Oncology; Internal medicine; Clinical trial; Chemotherapy; Context (archaeology); Docetaxel; Population; Androgen deprivation therapy; Cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01578633,0.0007588227,0.01447342,0.0002197548,0.0002077685,0.00004030547,0.000874815,0.00197659,0.0002266957],"category_scores_gemma":[0.001946601,0.0004181731,0.005950733,0.0002747464,0.003267999,0.0002034491,0.0001361845,0.00437495,0.000006071479],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000655837,"about_ca_system_score_gemma":0.04941761,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006501298,"about_ca_topic_score_gemma":0.000100165,"domain_scores_codex":[0.9832139,0.002019622,0.01181519,0.00100593,0.001169497,0.0007758297],"domain_scores_gemma":[0.9644981,0.01084016,0.02025023,0.0007698747,0.002532385,0.001109235],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.04919363,0.00563892,0.002878353,0.002444996,0.007688219,0.0001565721,0.00005467121,8.54492e-7,0.000003587065,0.00001841668,0.03670311,0.8952187],"study_design_scores_gemma":[0.03017825,0.1098329,0.009860979,0.003748048,0.001637213,0.0002031596,0.00007051894,0.00004458379,0.000003802478,0.00006060457,0.8440285,0.0003313952],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004072526,0.9730642,0.00006134689,0.01302133,0.002446222,0.005439131,0.0005921913,0.00002338669,0.001279628],"genre_scores_gemma":[0.0003939523,0.9776823,0.00957157,0.001135982,0.008127199,0.0002700974,0.0002213014,0.0001304012,0.00246718],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8948873,"threshold_uncertainty_score":0.999827,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4594685778874917,"score_gpt":0.6328043055020732,"score_spread":0.1733357276145815,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}